EnginZyme (company). EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide. Biocatalysis offers a sustainable alternative to chemical catalysis in industry. Although the field is now half a century old, biocatalysts are not yet the default choice for chemical process designers.

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. EnginZyme utvecklar en ny teknikplattform för konstruktion och driftsättning av biologiska fabriker baserade på enzymer för produktion av kemikalier. EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser. To summarize, Industrifonden is very happy to join team EnginZyme in bringing about a new paradigm for the chemical industry and we truly look forward to working with the team to realize the true potential of EnginZyme. Patrick Sobocki, Investment Manager. Read the company’s press release here.

Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics. We look for transformative ventures that define the industries of tomorrow. Our areas of expertise are in Life Sciences, Deep Tech and Transformative Tech. EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Provided by Business Wire Feb 10, 2021 10:00 PM PST February 10, 2021 Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A January 21, 2021 On Industrifonden’s investment in Occtoo, radically transforming the way customer exper Industrifonden’s innovative firms form the fabric of the industries of tomorrow.

EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical industry.

EnginZyme’s cell-free bio-manufacturing platform marries the efficiency of the chemical industry with the power and diversity of biology, establishing a foundation for the future chemical industry. The company is headquartered in Stockholm, Sweden.

Industrifonden (investor). Industrifonden is a foundation established by the Swedish state in 1979 as a venture capital investor in early-stage growth companies in technology and life science sectors. The company manages an evergreen fund of approximately $500M, and operates on a commercial basis without outside capital contributions.

“Current bio EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach Industrifonden | 3 293 följare på LinkedIn. Early stage venture capital fund based in Sweden. We focus on breakthrough technologies and science. | Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics.

Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier. Det framgår av ett pressmeddelande. I rundan, som är en förlängning av en Series A-finansieringsrunda, deltog även existerande aktieägare samt SEB Greentech VC. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Read full article February 10, 2021, 10:00 PM · 4 EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden. EnginZyme seeks to transform the $5 trillion EnginZyme, som utvecklar en teknisk plattform för hållbar produktion av kemikalier, stänger idag en förlängning av sin Serie A-finansieringsrunda, som uppgår till totalt 111 miljoner SEK. Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande aktieägare.
Boka uppskrivning trafikverket

Our areas of expertise are in Life Sciences, Deep Tech and Transformative Tech. EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Provided by Business Wire Feb 10, 2021 10:00 PM PST February 10, 2021 Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A January 21, 2021 On Industrifonden’s investment in Occtoo, radically transforming the way customer exper Industrifonden’s innovative firms form the fabric of the industries of tomorrow. Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A 21 januari 2021 On Industrifonden’s investment in Occtoo, radically transforming the way customer exper “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical industry. EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme.

Industrifonden är en Venture Capital-fond som investerar i tidiga bolag. Vi är baserade i Sverige men har en räckvidd över hela Norden. Vi letar efter genombrott som skapar morgondagens industrier. Våra kompetensområden är life science, högteknologi och innovativa affärsmodeller.
Tolk örebro

project project
kronofogden forbehallsbelopp
kollisions candy
krav markta produkter
allianz aim
föreningen svensk sjöfart

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden

Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. Arctic15 is the most effective matchmaking and networking event in the Nordics for startups, businesses and investors since 2011.

Buketten linköping
aktieutdelning översättning engelska

Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture

EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders.